| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Somatostatin receptor type 2 |
|---|
| Ligand | BDBM50136800 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_200674 (CHEMBL806165) |
|---|
| IC50 | 15.5±n/a nM |
|---|
| Citation |  Erchegyi, J; Waser, B; Schaer, JC; Cescato, R; Brazeau, JF; Rivier, J; Reubi, JC Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling. J Med Chem46:5597-605 (2003) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Somatostatin receptor type 2 |
|---|
| Name: | Somatostatin receptor type 2 |
|---|
| Synonyms: | SOMATOSTATIN SST2 | SRIF-1 | SS-2-R | SS2-R | SS2R | SSR2_HUMAN | SSTR2 | Somatostatin receptor type 2 (SSTR2) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 41344.94 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P30874 |
|---|
| Residue: | 369 |
|---|
| Sequence: | MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCG
NTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMT
VDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIY
AGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGI
RVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVL
TYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTL
LNGDLQTSI
|
|
|
|---|
| BDBM50136800 |
|---|
| n/a |
|---|
| Name | BDBM50136800 |
|---|
| Synonyms: | (4R,7S,10R,13S,16S,19S,22R,25S)-25-Amino-13-(4-amino-butyl)-19,22-dibenzyl-7-(4-hydroxy-benzyl)-10-((R)-1-hydroxy-ethyl)-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaaza-cyclohexacosane-4-carboxylic acid | CHEMBL407025 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C54H66N10O11S2 |
|---|
| Mol. Mass. | 1095.292 |
|---|
| SMILES | C[C@@H](O)[C@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](N)CSSC[C@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(O)=O |
|---|
| Structure | 
|
|---|
Search and Browse
